Skip to content

BD MAX™ ExK™ TNA-3 442827Recalls & reported problems

Becton, Dickinson And Company · BD MAX™ ExK™ TNA-3 · Class 1

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00382904428273), received between Jul 28, 2020 and Jul 28, 2020 — classified as 1 injury.

The most frequently reported specific device problem is “Incorrect, Inadequate or Imprecise Result or Readings” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Incorrect, Inadequate or Imprecise Result or Readings1

Patient problems

  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 28, 2020Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

    THE CUSTOMER REPORTED THAT WHILE USING BD SARS-COV-2 REAGENTS FOR BD MAX¿ SYSTEM A FALSE POSITIVE RESULT WAS OBTAINED BY THE LABORATORY PERSONNEL. THE PATIENT HAD A SECOND TEST PERFORMED AT ANOTHER FACILITY AND THAT RESULT WAS NEGATIVE. THE PATIENT HAD A PROLONGED HOSPITAL STAY DUE TO THE ERRONEOUS RESULT. EUA#: (B)(4).

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 10335415 ↗

Other CLINICAL SAMPLE CONCENTRATOR devices

All CLINICAL SAMPLE CONCENTRATOR devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page